Elliptic Laboratories A (ELABS.OL) Stock Price

Elliptic Laboratories A Price

Oslo Børs·CLOSED
2.84
​
Market closed

Revenue has compounded at 29.4% per year over the past 8 years to 75.72 M NOK. Elliptic Laboratories A's net margin stands at -182.5%, down from -21.8% several years earlier.

Elliptic Laboratories A stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Elliptic Laboratories A business model & stock analysis

Elliptic Laboratories ASA develops AI software using ultrasound and sensor-fusion algorithms for 3D gesture and presence sensing in smartphones, laptops, IoT devices, and automotive applications. The company targets enterprise clients in these markets, selling its proprietary AI platform as a solution for intuitive user interactions. Its products are integrated into devices by manufacturers seeking advanced sensing capabilities without additional hardware. The company operates from offices in San Francisco, Oslo, and Shanghai, leveraging its patented technology to serve global technology sectors. Elliptic Laboratories ASA’s revenue comes from licensing its AI platform to device manufacturers across smartphone, laptop, IoT, and automotive segments. The enterprise focuses on delivering sensor-based solutions that enhance user experience through gesture and presence detection. Its core offering is embedded in products where traditional touch interfaces are insufficient, providing a competitive edge for partners in consumer electronics and automotive industries. The company’s business model relies on selling its AI platform through licensing agreements with technology firms. By combining ultrasound with sensor-fusion algorithms, Elliptic Laboratories ASA offers a unique solution for 3D gesture control, which is adopted by manufacturers to improve device functionality. The enterprise targets global markets where touchless interaction is increasingly valued, particularly in high-end smartphones and automotive systems.

Frequently asked questions about Elliptic Laboratories A

9 analysts currently rate the Elliptic Laboratories A stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Elliptic Laboratories A to generate revenue of 99.54 M NOK and earnings per share of -0.16 NOK.

Converted at the current exchange rate, the Elliptic Laboratories A share trades at 0.27 EUR (2.84 NOK).

The Elliptic Laboratories A share (ELABS.OL) is listed on 6 stock exchanges, including: Osaka (JPX) (ELABS.OL), Frankfurt (EIP.F), München (EIP.MU), Stockholm (ELABSO.ST).

The expected revenue of Elliptic Laboratories A is 99.54 M NOK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Elliptic Laboratories A is -20.80 M NOK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Elliptic Laboratories A is currently -17.59. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Elliptic Laboratories A stock.

The price-to-sales ratio (P/S) of Elliptic Laboratories A is currently 3.68. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Elliptic Laboratories A stock.

The Eulerpool Quality Score for Elliptic Laboratories A is 4/10.

The ISIN of Elliptic Laboratories A is NO0010722283. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Elliptic Laboratories A is A2QFQQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Elliptic Laboratories A is ELABS.OL. The ticker symbol is used to trade Elliptic Laboratories A shares on the stock exchange.

Fair ValueTerminal
2.61 NOK
Over-/UndervaluationTerminal
Fairly valued
Industry
Software
Number of shares
Employees
Revenue per Employee
1.18 M NOK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Norway
Currency
NOK
Initial public offering
Oct 16, 2020
ISIN
NO0010722283
Cusip
R21796108
Market capitalization
299.02 M NOKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-17.59
P/Ee 2027
-157.12
P/Ee 2028
38.09
P/S
P/Se
3.68
EV/EBIT
—
P/B Ratio
1.58
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-69.75 %
Last updated Nov 19, 2026, 10:03 PM

Elliptic Laboratories A Peer Group

Elliptic Laboratories A Ticker

EURONEXT · ELABS.OLFRANKFURT · EIP.FMUNICH · EIP.MUOSE · ELABS.OLOSLO · ELABS.OLSTOCKHOLM · ELABSO.ST

Elliptic Laboratories A FIGI

ELABS:NO · BBG00XSL39K5ELABSNOK:EP · BBG00XWZ5VS0ELABSNOK:EZ · BBG00XWZ5VV6ELABSNOK:XS · BBG00XWZ5VW5ELABSNOK:X2 · BBG00XWZ5VX4ELABSNOK:XH · BBG00XWZ5VZ2ELABSNOK:XF · BBG00XWZ5W17ELABSNOK:XE · BBG00XWZ5W35ELABSNOK:XJ · BBG00XWZ5W44ELABSNOK:XL · BBG00XWZ5W53ELABSNOK:XG · BBG00XWZ5W62ELABSNOK:XO · BBG00XWZ5W71